Vinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin in Advanced Non-small Cell Lung Cancer
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore if the combination of vinorelbine and gemcitabine is
better than vinorelbine and carboplatin in the treatment of advanced non-small cell lung
cancer, in terms of survival, quality of life and need for palliative radiotherapy.